Showing results (2251-2260 of 19,555) with videos related to

Sort By:
Pageof 1,956
BMC Cancer|October 11, 2011
A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patientsMark J McKeage, Yongchuan Gu, William R Wilson, et al.
BMC Cancer|November 26, 2011
Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control studyFu-Hsiung Su, Shih-Ni Chang, Pei-Chun Chen, et al.
BMC Cancer|October 8, 2011
A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patientsSwetlana Rot, Helge Taubert, Matthias Bache, et al.
BMC Cancer|January 6, 2012
HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breastSophie Doublier, Dimas C Belisario, Manuela Polimeni, et al.
BMC Cancer|January 21, 2012
TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cellsLuciana R Gomes, Letícia F Terra, Rosângela Am Wailemann, et al.
BMC Cancer|January 21, 2012
Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cellsXinfeng Yu, Xuemei Zhang, Ishwori B Dhakal, et al.
BMC Cancer|March 9, 2012
The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancerTorben Frøstrup Hansen, Flemming Brandt Sørensen, Jan Lindebjerg, et al.
BMC Cancer|March 2, 2012
The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancerGustaf Rosin, Ulf Hannelius, Linda Lindström, et al.
BMC Cancer|April 13, 2012
Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cellsCornel J Phillip, Christopher K Giardina, Birdal Bilir, et al.
BMC Cancer|April 5, 2012
Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by siteFrederick Albright, Craig Teerlink, Theresa L Werner, et al.
Pageof 1,956